PHILIP CERAULO: Open Payments
NPI 1114180882 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 13 payments from 10 companies in 2025. Trend: 2023 $235 · 2024 $125 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Nalu Medical, Inc. | 1 | $127 |
| Boston Scientific Corporation | 2 | $94 |
| Medtronic, Inc. | 2 | $78 |
| ABBVIE INC. | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Abbott Laboratories | 1 | $19 |
| Forte Bio-Pharma LLC | 1 | $18 |
| Valinor Pharma, LLC | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Nalu Neurostimulation System, INCEPTIV, Intracept, WaveWriter Alpha Prime 16, VRAYLAR, SPRAVATO, PROCLAIM, PROLATE.
Industry payments across NJ — which companies pay providers there.
